Stifel Financial Corp Centogene N.V. Transaction History

Stifel Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.65 - $1.25 $650 - $1,250	1,000 Added 4.66%	22,450 $15,000
Q4 2023 Feb 12, 2024	BUY	$1.02 - $1.47 $5,100 - $7,350	5,000 Added 30.4%	21,450 $25,000
Q3 2023 Nov 13, 2023	BUY	$1.0 - $1.64 $500 - $820	500 Added 3.13%	16,450 $17,000
Q2 2023 Aug 14, 2023	BUY	$0.63 - $1.63 $10,048 - $25,998	15,950 New	15,950 $23,000

33.6K

Ticker CNTG
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,081,600
Market Cap $2.98M
Description
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.